ITI Pharma and Healthcare Fund Regular vs HDFC Pharma and Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
HDFC Pharma and Healthcare Fund - Regular (G)
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹208 Cr | ₹1383 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 28 Sep 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare Index |
| Turn Over | % | % |
| Expense Ratio | 2.35 | 2.17 |
| Manager | Rohan Korde | Dhruv Muchhal |
| ISIN Code | INF00XX01BL5 | INF179KC1HL7 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Month | -4.47% | -2.19% |
| 6 Month | 11.67% | 18.27% |
| 1 Year | 27.54% | 37.62% |
| 3 Year | 18.15% | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 20.98% | 33.18% |
| 3 Year | 27.81% | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Year | 22.17% | 62.28% |
| 3 Year | 19.97% | - |
| 5 Year | - | - |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Standard Deviation | 14.52% | - |
| Sharp | - | - |
| Beta | - | - |
| Alpha | - | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Name | Rohan Korde | Dhruv Muchhal |
| Total AUM | ₹4626 Cr | ₹520687 Cr |
| Fund Manage | 10 | 40 |
| ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 1.8 | 1.98 |
| Large Cap | 38.11 | 32.5 |
| Mid Cap | 26.43 | 32.4 |
| Small Cap | 33.66 | 33.12 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 1.8 | 1.98 |
| Pharmaceuticals & Biotechnology | 77 | 74.71 |
| Healthcare Services | 18.01 | 22.28 |
| Chemicals & Petrochemicals | 0.96 | - |
| Fertilizers & Agrochemicals | 1.03 | - |
| Insurance | 1.2 | - |
| Retailing | - | 1.03 |
Top Comparisons
Nippon India Power & Infra Fund-Growth Plan -Growth Option
3Y Returns27.55%
Sundaram Infrastructure Advantage Fund Regular Plan - Growth
3Y Returns18.28%
Franklin India Flexi Cap Fund - Growth
3Y Returns15.9%
Quant Flexi Cap Fund-Growth
3Y Returns16.72%
HDFC NIFTY200 Momentum 30 Index Fund - Regular (G)
3Y Returns0%
Aditya Birla SL Crisil IBX Gilt June 2027 Index Fund-Reg (G)
3Y Returns0%
Mahindra Manulife Balanced Advantage Fund - Regular Plan - Growth
3Y Returns11.05%
PGIM India Balanced Advantage Fund - Regular Growth
3Y Returns7.68%